Image Credit: STAT News
STAT+: Gilead is urged to rework licensing deals for groundbreaking HIV prevention drug
A group of academics is arguing that countries seeking access to a groundbreaking HIV prevention drug from Gilead Sciences may need to issue compulsory licenses.